Cargando…

Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2

Macular telangiectasia Type 2 (MacTel) is a bilateral acquired retinal disease characterized by both vascular changes and atrophy of the retina. The purpose of this case series is to highlight the use of optical coherence tomography angiography (OCTA) as a non-invasive imaging modality to distinguis...

Descripción completa

Detalles Bibliográficos
Autores principales: Moir, John, Amin, Shivam V., Khanna, Saira, Komati, Rahul, Shaw, Lincoln T., Dao, David, Hariprasad, Seenu M., Skondra, Dimitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321649/
https://www.ncbi.nlm.nih.gov/pubmed/35887197
http://dx.doi.org/10.3390/ijms23147849
_version_ 1784756099794075648
author Moir, John
Amin, Shivam V.
Khanna, Saira
Komati, Rahul
Shaw, Lincoln T.
Dao, David
Hariprasad, Seenu M.
Skondra, Dimitra
author_facet Moir, John
Amin, Shivam V.
Khanna, Saira
Komati, Rahul
Shaw, Lincoln T.
Dao, David
Hariprasad, Seenu M.
Skondra, Dimitra
author_sort Moir, John
collection PubMed
description Macular telangiectasia Type 2 (MacTel) is a bilateral acquired retinal disease characterized by both vascular changes and atrophy of the retina. The purpose of this case series is to highlight the use of optical coherence tomography angiography (OCTA) as a non-invasive imaging modality to distinguish atypical MacTel from other macular conditions with similar presentations. We performed a retrospective review of patients referred to our academic retinal practice with unconfirmed or misdiagnosed MacTel between July 2017 and July 2021. Patients’ OCTA imaging findings were reviewed to guide the appropriate diagnosis and management of atypical MacTel. Fifteen eyes from eight patients were included in this study. Six patients were referred with previous diagnoses of either full-thickness macular hole, lamellar hole, vitreomacular traction (VMT), postoperative cystoid macular edema (CME), or diabetic macular edema (DME). Two patients were referred to us to confirm the diagnosis of MacTel. OCTA revealed telangiectatic vessels in the temporal parafovea of all 15 eyes. OCTA also highlighted previously undiagnosed subretinal neovascularization (SRNV) in seven eyes. OCTA imaging is a valuable imaging modality to distinguish MacTel from other macular conditions, whose treatment courses vary substantially. Due to its ease of use, it holds immense potential in the future as treatments for non-proliferative MacTel emerge.
format Online
Article
Text
id pubmed-9321649
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93216492022-07-27 Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2 Moir, John Amin, Shivam V. Khanna, Saira Komati, Rahul Shaw, Lincoln T. Dao, David Hariprasad, Seenu M. Skondra, Dimitra Int J Mol Sci Article Macular telangiectasia Type 2 (MacTel) is a bilateral acquired retinal disease characterized by both vascular changes and atrophy of the retina. The purpose of this case series is to highlight the use of optical coherence tomography angiography (OCTA) as a non-invasive imaging modality to distinguish atypical MacTel from other macular conditions with similar presentations. We performed a retrospective review of patients referred to our academic retinal practice with unconfirmed or misdiagnosed MacTel between July 2017 and July 2021. Patients’ OCTA imaging findings were reviewed to guide the appropriate diagnosis and management of atypical MacTel. Fifteen eyes from eight patients were included in this study. Six patients were referred with previous diagnoses of either full-thickness macular hole, lamellar hole, vitreomacular traction (VMT), postoperative cystoid macular edema (CME), or diabetic macular edema (DME). Two patients were referred to us to confirm the diagnosis of MacTel. OCTA revealed telangiectatic vessels in the temporal parafovea of all 15 eyes. OCTA also highlighted previously undiagnosed subretinal neovascularization (SRNV) in seven eyes. OCTA imaging is a valuable imaging modality to distinguish MacTel from other macular conditions, whose treatment courses vary substantially. Due to its ease of use, it holds immense potential in the future as treatments for non-proliferative MacTel emerge. MDPI 2022-07-16 /pmc/articles/PMC9321649/ /pubmed/35887197 http://dx.doi.org/10.3390/ijms23147849 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Moir, John
Amin, Shivam V.
Khanna, Saira
Komati, Rahul
Shaw, Lincoln T.
Dao, David
Hariprasad, Seenu M.
Skondra, Dimitra
Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
title Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
title_full Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
title_fullStr Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
title_full_unstemmed Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
title_short Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
title_sort use of oct angiography to diagnose and manage atypical presentations of macular telangiectasia type 2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321649/
https://www.ncbi.nlm.nih.gov/pubmed/35887197
http://dx.doi.org/10.3390/ijms23147849
work_keys_str_mv AT moirjohn useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2
AT aminshivamv useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2
AT khannasaira useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2
AT komatirahul useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2
AT shawlincolnt useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2
AT daodavid useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2
AT hariprasadseenum useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2
AT skondradimitra useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2